New Phase 3 AFFIRM data show higher rates of clinical and endoscopic response in Crohn's disease patients treated with subcutaneous SKYRIZI versus placebo across all efficacy endpoints ...
Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...
Skyrizi (risankizumab-rzaa) is a brand-name drug that’s prescribed for adults with Crohn’s disease. This article covers topics such as side effects, dosage, and how Skyrizi works. Crohn’s disease is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results